Research Article| Volume 49, ISSUE 11, P1390-1394, November 2000

A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat


      This study was initiated to develop an animal model of type 2 diabetes in a non-obese, outbred rat strain that replicates the natural history and metabolic characteristics of the human syndrome and is suitable for pharmaceutical research. Male Sprague-Dawley rats (n = 31), 7 weeks old, were fed normal chow (12% of calories as fat), or high-fat diet (40% of calories as fat) for 2 weeks and then injected with streptozotocin (STZ, 50 mg/kg intravenously). Before STZ injection, fat-fed rats had similar glucose concentrations to chow-fed rats, but significantly higher insulin, free fatty acid (FFA), and triglyceride (TG) concentrations (P < .01 to .0001). Plasma insulin concentrations in response to oral glucose (2 g/kg) were increased 2-fold by fat feeding (P < .01), and adipocyte glucose clearance under maximal insulin stimulation was significantly reduced (P < .001), suggesting that fat feeding induced insulin resistance. STZ injection increased glucose (P < .05), insulin (P < .05), FFA (P < .05), and TG (P < .0001) concentrations in fat-fed rats (Fat-fed/STZ rats) compared with chow-fed, STZ-injected rats (Chow-fed/STZ rats). Fat-fed/STZ rats were not insulin deficient compared with normal chow-fed rats, but had hyperglycemia and a somewhat higher insulin response to an oral glucose challenge (both P < .05). In addition, insulin-stimulated adipocyte glucose clearance was reduced in Fat-fed/STZ rats compared with both chow-fed and Chow-fed/STZ rats (P < .001). Finally, Fat-fed/STZ rats were sensitive to the glucose lowering effects of metformin and troglitazone. In conclusion, Fat-fed/STZ rats provide a novel animal model for type 2 diabetes, simulates the human syndrome, and is suitable for the testing of antidiabetic compounds. Copyright © 2000 by W.B. Saunders Company
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Further reading

        • Lillioja S
        • Mott DM
        • Spraul M
        • et al.
        Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus.
        N Engl J Med. 1993; 329: 1988-1992
        • Warram JH
        • Martin BC
        • Krowleski AS
        • et al.
        Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic patients.
        Ann Intern Med. 1990; 113: 909-915
        • Reaven GM
        • Chen Y-DI
        • Hollenbeck CB
        • et al.
        Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
        J Clin Endocrinol Metab. 1993; 76: 44-48
        • Reaven GM
        • Ho H
        Low-dose streptozotocin-induced diabetes in the spontaneously hypertensive rat.
        Metabolism. 1991; 40: 335-337
        • Mondon CE
        • Reaven GM
        Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension.
        Metabolism. 1988; 37: 303-305
        • Reaven GM
        • Chang H
        • Hoffman BB
        • et al.
        Resistance to insulin-stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats.
        Diabetes. 1989; 38: 1155-1160
        • Kraegen EW
        • James DE
        • Storlien LH
        • et al.
        In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: Assessment by euglycemic clamp plus deoxyglucose administration.
        Diabetologia. 1986; 29: 192-198
        • Kraegen EW
        • Clark PW
        • Jenkins AB
        • et al.
        Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats.
        Diabetes. 1991; 40: 1397-1403
        • Storlien LH
        • James DE
        • Burleigh KM
        • et al.
        Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure and obesity in the rat.
        Am J Physiol. 1986; 251: E576-E583
        • Foley JE
        • Kashiwagi A
        • Verso MA
        • et al.
        Improvement in in vitro insulin action after one month of insulin therapy in obese noninsulin-dependent diabetics.
        J Clin Invest. 1983; 72: 1901-1909
        • Kashiwagi A
        • Verso MA
        • Andrews J
        • et al.
        In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus.
        J Clin Invest. 1983; 72: 1246-1254
        • Rodbell M
        Metabolism of isolated fat cells. 1. Effects of hormones on glucose metabolism and lipolysis.
        J Biol Chem. 1964; 239: 375-380
        • Cushman SW
        • Salans LB
        Determination of adipose cell size and number in suspensions of isolated rat and human adipose cells.
        J Lipid Res. 1978; 19: 269-273
        • Albrink MJ
        Dietary and drug treatment of hyperlipidemia in diabetes.
        Diabetes. 1974; 23: 913-918
        • Lewis GF
        • O'Meara NM
        • Soltys PA
        • et al.
        Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities.
        J Clin Endocrinol Metab. 1991; 72: 934-944
        • Blondel O
        • Bailbé D
        • Portha B
        Relation of insulin deficiency to impaired insulin action in NIDDM adult rats given streptozocin as neonates.
        Diabetes. 1989; 38: 610-617
        • Portha B
        • Levacher C
        • Picon L
        • et al.
        Diabetogenic effect of streptozocin in the rat during the perinatal period.
        Diabetes. 1974; 23: 889-895
        • Weir GC
        • Clore ET
        • Zmachinski CJ
        • et al.
        Islet secretion in a new experimental model for non-insulin-dependent diabetes.
        Diabetes. 1981; 30: 590-595
        • Pascoe WS
        • Storlien LH
        Inducement of basal hyperglycemia in rats with abnormal B-cell function by fat-feeding: Model for study of aetiology and pathogenesis of NIDDM.
        Diabetes. 1990; 39: 226-233
        • Pascoe WS
        • Jenkins AB
        • Kusinoki M
        • et al.
        Insulin action and determinants of glycaemia in a rat model of type 2 (non-insulin-dependent) diabetes mellitus.
        Diabetologia. 1992; 35: 208-215
        • Peterson RG
        • Shaw WN
        • Neel M-A
        • et al.
        Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus.
        Inst Lab Anim Resources News. 1990; 32: 16-19